Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87620 refers to the detection of infectious agents through nucleic acid testing, specifically targeting the human papillomavirus (HPV) using a direct probe technique. HPV is a prevalent sexually transmitted disease that affects both men and women, with over 40 different types capable of infecting the genital areas. While some HPV types lead to the development of genital warts, others are associated with more serious health risks, including various cancers such as cervical, vulvar, vaginal, anal, and penile cancers. The nucleic acid tests, particularly those indicated by this code, are crucial for identifying specific HPV types that are known to cause cancer, including HPV types 6, 11, 16, and 18. The testing process involves obtaining scrapings from the cervix, vagina, male urethra, or anus, depending on the patient’s anatomy and clinical indications. The methodology for this test can vary based on the manufacturer of the test kit, but it typically employs a nucleic acid hybridization method. This involves using a single-stranded chemiluminescent DNA probe that is complementary to the ribosomal RNA of the specific HPV type being tested. To facilitate the release of nucleic acids, a lysate is utilized to rupture the cells. The ribosomal RNA from the HPV then binds with the labeled DNA probe, forming a stable DNA:RNA hybrid. The presence of these hybrids is subsequently detected using a luminometer, which measures the luminescence produced during the reaction. This process is essential for accurately diagnosing HPV infections and determining the appropriate clinical management for affected individuals.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 87620 is indicated for the detection of human papillomavirus (HPV) in patients who may present with symptoms or conditions associated with HPV infection. The following are specific indications for performing this test:
The procedure for CPT® Code 87620 involves several key steps to ensure accurate detection of HPV. The following outlines the procedural steps:
After the procedure associated with CPT® Code 87620, the patient may not require any specific post-procedure care, as the test is non-invasive and does not involve surgical intervention. However, it is essential for healthcare providers to communicate the results of the test to the patient once they are available. Patients may need to discuss the implications of the results, especially if high-risk HPV types are detected, which may necessitate further evaluation or management. Follow-up appointments may be scheduled to monitor the patient's health status and to provide guidance on preventive measures, such as vaccination against HPV.
| Short Descr | HPV DNA DIR PROBE | Medium Descr | IADNA PAPILLOMAVIRUS HUMAN DIRECT PROBE TQ | Long Descr | Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human, direct probe technique | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
Get instant expert-level medical coding assistance.